Rocky Mountain Advisers, LLC Maia Biotechnology, Inc. Transaction History
Rocky Mountain Advisers, LLC
- $125 Million
- Q4 2025
A detailed history of Rocky Mountain Advisers, LLC transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Rocky Mountain Advisers, LLC holds 653 shares of MAIA stock, worth $679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
653Holding current value
$679% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
23Shares Held
2.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.15MShares$1.2 Million0.0% of portfolio
-
Centric Wealth Management575KShares$597,8930.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$281,8980.0% of portfolio
-
Marshall Wace, LLP London, X0110KShares$114,8850.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$81,6610.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $11.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...